EFFICIENCY OF BACTERIAL IMMUNOMODULATOR BLASTOLEN IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CHRONIC bronchitis

Journal Title: Астма и Аллергия - Year 2018, Vol 1, Issue 3

Abstract

The objective: To evaluate the efficacy of Blastolen on the amount of exacerbations observed during the year and its effect on the state of the immune system of patients with chronic obstructive pulmonary disease and chronic bronchitis. The work is done at the expense of the state budget. 17 patients were examined, which were observed in the SO «National institute of phthisiology and pulmonology named after F. G. Yanovsky NAMS of Ukraine», the middle age (61,1 ± 1,9) years. Among them there were 10 patients with chronic obstructive pulmonary disease in the remission phase, including 3 patients in group B, 2 patients in group C, 5 patients in group D, and 7 patients with chronic bronchitis in remission phases. The control group consisted of 17 volunteers (blood donors) without clinical signs of somatic and infectious diseases in age (48.9 ± 2.8) years. Patients were prescribed Blastolen intramuscularly for 0.6 mg once a week for 5 weeks (5 injections). Immunological examination of peripheral blood of patients was performed twice before the appointment of the immunomodulator and 2–3 weeks after completion of the Blastolen course (only 7–8 weeks after starting treatment). Six months later and one year after Blastolen injection, a telephone questionnaire was conducted for patients. Results: The application of the course of injections of Blastolen during the remission of chronic obstructive pulmonary disease or chronic bronchitis is accompanied by an immunomodulatory effect on phagocytes (an increase in the functional reserve of neutrophil granulocytes), as well as a decrease in the markers of the inflammatory process – the level of small circulating immune complexes and the concentration of C-reactive protein in the blood of patients, which leads to a reduction in the duration and frequency of exacerbations of the disease during observation during the year.

Authors and Affiliations

O. M. Rekalova, O. R. Panasyukova, Yu O Matviienko, N. I. Grabchenko, M. B. Singhayevsky

Keywords

Related Articles

FEATURES OF POLLINIC SENSITIZATION IN PATIENTS WITH POLLINOSIS IN THE CITY OF DNIPRO

Hay fever is an allergic disease of the mucous membranes due to hypersensitivity to airborne allergens, when their air concentration periodically becomes causative. The main task of the specific diagnosis of hay fever is...

DIFFERENT METHODS OF DERMATOPHAGOIDES FARINAE SENSITIZATION DETERMINATION IN PATIENTS WITH RESPIRATORY ALLERGY

Objective was to study and compare the parameters of the specificity and sensitivity of skin testing and serologic determination of specific Dermatophagoides farinae IgE. Materials and methods . 88 patients with aller...

ROLE OF ELIMINATION MEASURES IN THE TREATMENT OF PATIENTS WITH ALLERGIC DISEASES

Introduction. The importance of elimination measures as an essential component of an integrated approach to the treatment and prevention of allergic diseases is often underestimated by doctors and patients. The article...

Usage of medical thermography to evaluate the results of skin prick testing of patients with allergic rhinitis

Метою дослідження було вивчення аспектів використання медичної термографії для оцінки результатів шкірного тестування розчинами алергенів у пацієнтів з алергічним ринітом у порівнянні з імуноблотингом. Матеріали та...

Evaluation day activity of patients with bronchial asthma in dependence on the clinical variant of the disease

Основною метою проведеної роботи було оцінити денний спосіб життя хворих на бронхіальну астму (БА) в залежності від конт- рольованості перебігу захворювання. Матеріали та методи. Дослідження проводилися на базі ДУ...

Download PDF file
  • EP ID EP408299
  • DOI 10.31655/2307-3373-2018-3-19-23
  • Views 177
  • Downloads 0

How To Cite

O. M. Rekalova, O. R. Panasyukova, Yu O Matviienko, N. I. Grabchenko, M. B. Singhayevsky (2018). EFFICIENCY OF BACTERIAL IMMUNOMODULATOR BLASTOLEN IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CHRONIC bronchitis. Астма и Аллергия, 1(3), 19-23. https://www.europub.co.uk/articles/-A-408299